Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by pidukson Jun 20, 2024 11:10am
52 Views
Post# 36097902

RE:RE:Center for Disease Control (CDC U.S.) and avian bird flu

RE:RE:Center for Disease Control (CDC U.S.) and avian bird fluThere is a great deal of fear within the organizataions of the FDA, CDC, NIH, and Health Canada because avian bird flu easily crossed into mammals including humans along with the 20%+ death rate. Currently, vaccine makers are unable to ramp and meet orders for avian bird flu vaccines from the CDC because their production lines are currently making seasonal flu vaccines for this Fall/Winter season.   

Do not be at all surprised to see a 'government organization' issue an order to Medipharm Labs for pharmaceutical grade inhalers.   Today's news from Medipharm Labs emphasized medical and pharmaceutical grade inhalers and the NIH May 2022 research paper referencing CBD-X included it's effectiveness against lung inflammation brought on by avian bird flu.

Personally I believe today's news is only the tip of the iceburg especially with the very high mortality rate of avian bird flu.   

The clock is ticking and ticking fast because by late Summer/early Fall the bird flight paths will be busy with migratory birds migrating south in North America from the far north.   If you look at all the dairy farms infected with avian bird flu in the U.S., they line up with the major flight paths.  

Many pig, chicken, and dairy farms have ponds for their sources of live stock water and migratory birds stop to rest within these small ponds.   

How global is the spread of avian bird flu?  They found dead seals in Antarctica, lungs filled due to avian bird flu infections.


<< Previous
Bullboard Posts
Next >>